LGT Group Foundation Boosts Johnson & Johnson Stake

Institutional investor increases holdings in pharmaceutical giant by 7.9%

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

LGT Group Foundation, a prominent investment firm, has increased its stake in Johnson & Johnson (NYSE: JNJ) by 7.9% in the third quarter, according to a recent SEC filing. The fund now owns 369,852 shares of the company's stock, worth approximately $68.8 million.

Why it matters

Johnson & Johnson is a bellwether stock in the healthcare sector, and institutional investors' moves can signal broader market sentiment. The increase in LGT Group Foundation's stake suggests confidence in J&J's long-term prospects, despite recent legal and regulatory challenges the company has faced.

The details

According to the filing, LGT Group Foundation purchased an additional 27,059 shares of Johnson & Johnson during the third quarter. This brings the firm's total holdings in J&J to 369,852 shares, or approximately 0.8% of the company's outstanding stock. The investment represents a 7.9% increase in LGT's position compared to the prior quarter.

  • LGT Group Foundation increased its Johnson & Johnson stake in the third quarter of 2026.

The players

LGT Group Foundation

A prominent investment firm that manages assets on behalf of the Princely Family of Liechtenstein.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer packaged goods.

Got photos? Submit your photos here. ›

The takeaway

The increase in LGT Group Foundation's Johnson & Johnson holdings suggests continued institutional confidence in the pharmaceutical giant, despite recent legal and regulatory challenges. As a bellwether stock, J&J's performance is closely watched by investors and analysts alike.